MedTrace Logo

Clinical Study With the seleXys PC and the RM Pressfit Vitamys Cup

NCT03260465 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2025-02-19

No results posted yet for this study

Summary

This is a randomized controlled trial with the seleXys PC cup and RM Pressfit vitamys cup in combination with the optimys short stem. Wear rate and migration is assessed with roentgen stereophotogrammetric analysis (RSA) measurements.

Conditions

  • Hip Joint
  • Arthritis, Degenerative

Interventions

DEVICE

seleXys PC

Total hip arthroplasty using the seleXys PC cup

DEVICE

RM

Total hip arthroplasty using the RM cup

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Karl Stoffel, Prof. Dr. med. · Klinik für Orthopädie und Traumatologie, Universitätsspital Basel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-30
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • Switzerland

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03260465 on ClinicalTrials.gov